Saturday 1 November 2025
Home      All news      Contact us      RSS     
theepochtimes - 3 years ago

FDA Panel Backs Restricted Use of AstraZeneca’s Prostate Cancer Drug

A panel of U.S. Food and Drug Administration (FDA) advisers on Friday voted for the restricted use of British drugmaker AstraZeneca Plc. s experimental treatment, jointly developed with Merck #38; Co., for a type of prostate cancer. The FDA panel voted 11–1 with one abstention, in favor of Lynparza, in combination with other medications—abiraterone and prednisone [ ]


Latest News
Hashtags:   

Panel

 | 

Backs

 | 

Restricted

 | 

AstraZeneca

 | 

Prostate

 | 

Cancer

 | 

Sources